Impact of Regular or Extended Hemodialysis and Hemodialfiltration on Plasma Oxalate Concentrations in Patients With End-Stage Renal Disease
Theresa Ermer(Friedrich-Alexander-Universität Erlangen-Nürnberg), Felix Knauf(Mayo Clinic), Thomas D. Nolin(Yamaha (Japan)), Mark A. Perazella(Yale University), Ignacio Granja(LabCorp (United States)), Martin Reichel(Friedrich-Alexander-Universität Erlangen-Nürnberg), Christoph Kopp(Friedrich-Alexander-Universität Erlangen-Nürnberg), Peter S. Aronson(Yale University), Kai‐Uwe Eckardt(Friedrich-Alexander-Universität Erlangen-Nürnberg), Fredric O. Finkelstein(Yale University), John R. Asplin(Link Foundation)
Cited by 21
Related Papers
Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
|Kidney International|2005|3.9k
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report
|Kidney International|2010|2.3k
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia
|New England Journal of Medicine|2006|2.1k
Chronic kidney disease as a global public health problem: Approaches and initiatives – a position statement from Kidney Disease Improving Global Outcomes
|Kidney International|2007|1.5k
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
|American Journal of Transplantation|2009|1.5k